Impact of hepatitis C virus co-infection on HIV patients before and after highly active antiretroviral therapy: an immunological and clinical chemistry observation, Addis Ababa, Ethiopia

Table 1 Mean baseline and fourth year CD4 ⁺ and CD8 ⁺ cell count of under HAART subjects

Cells/μl	Year	HIV/HCV co-infected (G2) (n = 16) Mean ± SD	HIV mono-infected (G1) (n = 16) Mean ± SD	p value
CD4⁺	1^st year	148 ± 30	80 ± 151	P < 0.002
CD4⁺	4^th year	343 ± 119	426 ± 113	P < 0.004
CD8⁺	1^st year	1104 ± 420	950 ± 631	P < 0.003
	4^th year	1259 ± 430	1247 ± 420	N/S

(Number of patients in parenthesis), N/S- not significant.
Key: G = Group, HAART = highly active antiretroviral therapy, ART = Antiretroviral treatment, μl = microliter, CD = Cluster designation/differentiation, SD = standard deviation.

ISSN: 1471-2172